Yang Y, Patel J, Yang R, Ma F, Niu X, Zhang Y
Anal Bioanal Chem. 2024; 417(4):847-859.
PMID: 39688670
DOI: 10.1007/s00216-024-05707-w.
Llanes D, Rennert R, Janicke P, Morgan I, Reguera L, Rivera D
Front Pharmacol. 2024; 15:1408091.
PMID: 39600359
PMC: 11589458.
DOI: 10.3389/fphar.2024.1408091.
Zeng H, Ning W, Liu X, Luo W, Xia N
Front Med. 2024; 18(4):597-621.
PMID: 39039315
DOI: 10.1007/s11684-024-1072-8.
Walther R, Park M, Ashman N, Welch M, Carroll J, Spring D
Chem Commun (Camb). 2024; 60(55):7025-7028.
PMID: 38888299
PMC: 11223184.
DOI: 10.1039/d4cc01558d.
Gu Y, Wang Z, Wang Y
Acta Pharm Sin B. 2024; 14(5):1965-1986.
PMID: 38799638
PMC: 11119582.
DOI: 10.1016/j.apsb.2024.01.009.
Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview.
Liu X, Cheng Y, Mu Y, Zhang Z, Tian D, Liu Y
Front Immunol. 2024; 15:1328145.
PMID: 38298192
PMC: 10828056.
DOI: 10.3389/fimmu.2024.1328145.
Targeted Glioma Therapy-Clinical Trials and Future Directions.
Shikalov A, Koman I, Kogan N
Pharmaceutics. 2024; 16(1).
PMID: 38258110
PMC: 10820492.
DOI: 10.3390/pharmaceutics16010100.
Resistance to antibody-drug conjugates in breast cancer: mechanisms and solutions.
Chen Y, Xu Y, Shao Z, Yu K
Cancer Commun (Lond). 2022; 43(3):297-337.
PMID: 36357174
PMC: 10009672.
DOI: 10.1002/cac2.12387.
Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate.
Lo C, Chiu T, Liu Y, Pan P, Liu K, Hsu C
J Med Chem. 2022; 65(19):12802-12824.
PMID: 36153998
PMC: 9574934.
DOI: 10.1021/acs.jmedchem.2c00631.
Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates.
Carboni F, Kitowski A, Sorieul C, Veggi D, Marques M, Oldrini D
Chem Sci. 2022; 13(8):2440-2449.
PMID: 35310500
PMC: 8864718.
DOI: 10.1039/d1sc01928g.
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates.
Kang M, Kong T, Khoo J, Loh T
Chem Sci. 2021; 12(41):13613-13647.
PMID: 34760149
PMC: 8549674.
DOI: 10.1039/d1sc02973h.
Tackling solid tumour therapy with small-format drug conjugates.
Deonarain M, Xue Q
Antib Ther. 2021; 3(4):237-245.
PMID: 33928231
PMC: 7990258.
DOI: 10.1093/abt/tbaa024.
Antibody Conjugates-Recent Advances and Future Innovations.
Leung D, Wurst J, Liu T, Martinez R, Datta-Mannan A, Feng Y
Antibodies (Basel). 2020; 9(1).
PMID: 31936270
PMC: 7148502.
DOI: 10.3390/antib9010002.
Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?.
Deonarain M, Yahioglu G, Stamati I, Pomowski A, Clarke J, Edwards B
Antibodies (Basel). 2019; 7(2).
PMID: 31544868
PMC: 6698822.
DOI: 10.3390/antib7020016.
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate.
Raposo Moreira Dias A, Pina A, Dean A, Lerchen H, Caruso M, Gasparri F
Chemistry. 2018; 25(7):1696-1700.
PMID: 30452790
PMC: 6471013.
DOI: 10.1002/chem.201805447.
Construction of homogeneous antibody-drug conjugates using site-selective protein chemistry.
Akkapeddi P, Azizi S, Freedy A, Cal P, Gois P, Bernardes G
Chem Sci. 2018; 7(5):2954-2963.
PMID: 29997785
PMC: 6005007.
DOI: 10.1039/c6sc00170j.
A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging.
Stenton B, Oliveira B, Matos M, Sinatra L, Bernardes G
Chem Sci. 2018; 9(17):4185-4189.
PMID: 29780549
PMC: 5941270.
DOI: 10.1039/c8sc00256h.
Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2.
Cazzamalli S, Ziffels B, Widmayer F, Murer P, Pellegrini G, Pretto F
Clin Cancer Res. 2018; 24(15):3656-3667.
PMID: 29691298
PMC: 6126628.
DOI: 10.1158/1078-0432.CCR-17-3457.
Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.
Cazzamalli S, Dal Corso A, Widmayer F, Neri D
J Am Chem Soc. 2018; 140(5):1617-1621.
PMID: 29342352
PMC: 5844464.
DOI: 10.1021/jacs.7b13361.
Development of Antibody-Directed Therapies: Quo Vadis?.
Rodrigues T, Bernardes G
Angew Chem Int Ed Engl. 2018; 57(8):2032-2034.
PMID: 29341367
PMC: 5838556.
DOI: 10.1002/anie.201712185.
